Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mismatch Repair01:20

Mismatch Repair

4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

875
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
875
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Master Transcription Regulators02:23

Master Transcription Regulators

6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells.

Molecular cancer therapeutics·2026
Same author

Global Proteomics Investigation of SAMT-247 Targets: An Antiviral Thioester that Acetylates Zinc Finger Proteins.

bioRxiv : the preprint server for biology·2026
Same author

p53-induced RNA-binding protein ZMAT3 inhibits transcription of a hexokinase to suppress mitochondrial respiration in human cancer cells.

eLife·2026
Same author

'When I got pregnant, I was really scared': US youth in foster care's perspectives on pregnancy and parenting while in care.

Culture, health & sexuality·2026
Same author

Beyond advisory boards: Youth engagement in nursing research for coalitions and action.

Nursing outlook·2026
Same author

Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.

Molecular cancer therapeutics·2025
Same journal

Ciliary flow and morphology shape mass transport at the surface and within gastrovascular cavities of black corals.

Communications biology·2026
Same journal

Virus-mediated prokaryotic community adaptation dynamics under thermal stress in municipal organic solid waste microbiomes.

Communications biology·2026
Same journal

Multi-omics insights into the woolly trait of Saussurea medusa and the plant's coordinated regulation of flavonoid biosynthesis.

Communications biology·2026
Same journal

Loss contexts enhance dorsolateral prefrontal interpersonal neural synchrony during successful human deceptive recommendations.

Communications biology·2026
Same journal

Neuro-regulator role of H<sub>2</sub>S in astrocyte activation and its effects on neurological damage and behavior of VPA-exposed rats.

Communications biology·2026
Same journal

Temporal orchestration of transcriptional and epigenomic programming underlying maternal embryonic diapause in a cricket model.

Communications biology·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2025

CD Spectroscopy to Study DNA-Protein Interactions
06:48

CD Spectroscopy to Study DNA-Protein Interactions

Published on: February 10, 2022

6.7K

SMARCD1 is an essential expression-restricted metastasis modifier.

Christina Ross1, Li-Yun Gong1,2, Lisa M Jenkins3

  • 1Laboratory of Cancer Biology and Genetics, Metastasis Susceptibility Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Communications Biology
|October 10, 2024
PubMed
Summary
This summary is machine-generated.

Researchers identified a new class of "essential expression-restricted" genes that regulate breast cancer metastasis. Targeting these genes, like Smarcd1, may offer new therapeutic strategies for late-stage patients.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

23.3K

Related Experiment Videos

Last Updated: Jun 10, 2025

CD Spectroscopy to Study DNA-Protein Interactions
06:48

CD Spectroscopy to Study DNA-Protein Interactions

Published on: February 10, 2022

6.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

23.3K

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Evolutionary Biology

Background:

  • Breast cancer is the most common cancer globally, with metastasis being the primary cause of mortality.
  • Current therapies for late-stage breast cancer, particularly metastasis, have limited efficacy.
  • Understanding transcriptional regulation is crucial for developing targeted treatments.

Purpose of the Study:

  • To identify novel therapeutic targets for breast cancer metastasis.
  • To investigate the role of RNA-binding proteins (NANOS1, PUM2, CPSF4) and their targets in metastasis.
  • To explore the concept of

Main Methods:

  • Meiotic genetics to study inherited transcriptional network regulation.
  • Analysis of RNA-binding proteins (NANOS1, PUM2, CPSF4) and their role in metastasis.
  • Utilized mouse models and clinical data to validate findings, focusing on Smarcd1 mRNA expression levels.

Main Results:

  • Identified a novel class of "essential expression-restricted" genes involved in metastasis.
  • Demonstrated that NANOS1, PUM2, and CPSF4 regulate metastatic potential, targeting Smarcd1 mRNA.
  • Found that intermediate Smarcd1 expression correlates with poor survival, while high/low expression is linked to better outcomes.

Conclusions:

  • Therapeutic targeting of "essential expression-restricted" genes, by modulating their expression levels, presents a novel strategy for breast cancer metastasis.
  • Smarcd1 serves as a key example, with precise expression levels critical for metastasis.
  • This approach offers potential for subtype-specific treatments to improve outcomes for late-stage breast cancer patients.